GLP-1 Revolution
by Amaltash Advisors LLC
$330.00
+9.76% past month
Nov 16, 2026
$335.52-0.72%
Nov 13, 2026
$337.97-0.83%
Comparable listed companies in commercial physical and biological research fell 1.08% on average, with all 3 of 3 declining . The company's 0.83% decline came alongside that sector-wide weakness and was somewhat smaller than the cohort average .
Nov 12, 2026
$340.81-0.55%
Comparable listed companies in commercial physical and biological research fell 0.97% on average, with all 3 of 3 declining . The company's 0.55% fall came alongside that cohort decline, though it was smaller.
Nov 11, 2026
$342.69-0.90%
Nov 10, 2026
$345.80-2.13%
Comparable listed companies in commercial physical and biological research fell 1.29% on average, with all 3 of 3 declining . CRL's 2.13% drop came alongside that sector decline and was somewhat steeper than the peer average .
Nov 9, 2026
$353.34+4.69%
Seeking Alpha reported that Charles River would acquire Frontage's bioanalysis and DMPK operations for $470M in cash . Comparable listed companies rose 2.50% on average, with all 3 of 3 higher . The company's 4.69% gain was therefore larger than the cohort's move .
Nov 6, 2026
$337.52+7.83%
Charles River shares rose 7.83%, outpacing comparable listed research companies, which rose 2.29% on average with all three rising . Seeking Alpha published the company's third-quarter 2026 results earnings call presentation that day .
Closing prices for CRL. Summaries describe past sessions only and are not advice, a forecast or a recommendation.
Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.
Prices and financial data are historical and provided for research only. Not investment advice.
As of Nov 16, 2026, Charles River Laboratories International, Inc. is 10.8% below its 52-week high. Its largest decline in the period shown was -74.3% (Nov 18, 2021 to Apr 11, 2025).
As of Nov 16, 2026, Charles River Laboratories International, Inc. closed 10.8% below its 52-week closing high, set on Oct 29, 2026.
Charles River Laboratories International, Inc. fell 74.3% from Nov 18, 2021 to Apr 11, 2025, close to close, the largest decline in daily data since Nov 18, 2021. It had not closed back above that high as of Nov 16, 2026.
Learn how max drawdown is measured, and how past market drawdowns played out.
Daily closing prices from Nov 18, 2021 to Nov 16, 2026, adjusted for splits but not dividends. Past price movements do not predict future results.
How much would it be worth today? $1,000 invested in Charles River Laboratories International, Inc. (CRL) 10 years ago, at the Nov 30, 2016 close, would be worth about $4,719 today, based on the Nov 16, 2026 close — a gain of $3,719 (+371.9%), dividends not included. Along the way it fell as much as 78.3% from a high, between Sep 2021 and Apr 11, 2025. Before Nov 2021 this uses monthly highs and lows.
Return calculator
Worth today, at the Nov 16, 2026 close
$28,730
+$15,830 · +122.7%The cash line is the same deposits earning nothing. A savings account would usually have paid some interest.
Past performance of CRL's closing prices (split-adjusted; dividends not included). It ignores fees, taxes and trading costs. The results change as prices update and with the amounts you enter. Past results do not predict future results, and a single stock can fall hard. We show this for every asset in our directory; it is not a recommendation to buy or sell CRL.
Try the full investment calculatorThe coffee test
A $5 coffee every workday comes to about $100 a month. Over 5 years that's 1,200 coffees, or $6,000.
The same $100 a month put into CRL since November 2021 would be worth $9,836 today.
That's 1,967 coffees. Make it a large.
Past performance, month-end prices. Not a forecast.
| Invested | Start date | CRL price then | $1,000 → | $10,000 → | Change |
|---|---|---|---|---|---|
| 1 year | Nov 28, 2025 | $178.14 | $1,883 | $18,835 | +88.3% |
| 3 years | Nov 30, 2023 | $197.08 | $1,702 | $17,025 | +70.2% |
| 5 years | Nov 30, 2021 | $365.87 | $917 | $9,170 | -8.3% |
| 10 years | Nov 30, 2016 | $71.10 | $4,719 | $47,190 | +371.9% |
$10,000 invested in Charles River Laboratories International, Inc. (CRL) at the Nov 30, 2016 close would have been worth about $47,190 at the Nov 16, 2026 close — a gain of $37,190 (+371.9%), dividends not included.
CRL closed at $71.10 on Nov 30, 2016 (split-adjusted). It closed at $335.52 on Nov 16, 2026.
Putting $100 into CRL at each month-end close from Nov 30, 2016 — 120 purchases, $12,000 in total — would have been worth about $24,483 at the Nov 16, 2026 close: a gain of $12,483 (+104.0%), dividends not included.
CRL closed at $335.52 on Nov 16, 2026. A year earlier it closed at $167.81 on Nov 14, 2025, so it is up 99.9% over that year. Five years earlier it closed at $448.68 on Oct 29, 2021 (down 25.2% since then). Its highest close in the year to Nov 16, 2026 was $376.10 on Oct 29, 2026, and its lowest was $149.93 on May 18, 2026. These are split-adjusted closing prices; dividends are not included.
CRL last closed at $335.52 on Nov 16, 2026. This page is updated once a day, so it does not show live prices.
Over one year, from $167.81 on Nov 14, 2025 to $335.52 on Nov 16, 2026, it was up 99.9%. Over five years, from $448.68 on Oct 29, 2021 to $335.52 on Nov 16, 2026, it was down 25.2%. These are split-adjusted closing prices; dividends are not included.
As of Nov 16, 2026, Charles River Laboratories International, Inc. had a market value (market cap) of about $16.2 billion.
Charles River Laboratories helps drug makers test new medicines before people take them. It breeds lab mice and rats, and runs safety tests and quality tests.
We do not tell anyone whether to buy or sell CRL, and past results do not predict future results. Its largest fall from a high since Nov 18, 2021 was 74.3%, from $387.51 on Nov 18, 2021 to $99.75 on Apr 11, 2025. A single stock can lose much of its value, so think about how much you could afford to lose. Our investment calculator shows how past amounts would have changed.
Past performance of CRL's closing prices. Not a forecast. This is general information, not a recommendation to buy or sell CRL.
Try the full investment calculatorThese strategies on Amaltash hold CRL today. We show them so you can see where it is used. This is not a recommendation to invest in any of them.
by Amaltash Advisors LLC